Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /NWPN
chevron_leftBack

The Now Corp.

NWPN
OTCMKTS: NWPN Delayed
0.0001USD 0%
As of 24 April 2025, The Now Corp. has a market cap of $732.33K USD, ranking #39067 globally and #5623 in the United States. It ranks #3972 in the Healthcare sector, and #844 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
39067
Country Rank
5623
Sector Rank
3972
Industry Rank
844
Key Stats
Market Cap
$732.33KUSD
Enterprise Value
$36.74MUSD
Net Income (TTM)
-$2.77MUSD
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Alfredo Papadakis open_in_new
Employees
1
Founded
1993
Website
thenowcorporation.net open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 0% 10K% -33% 0% -33%

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
NWPN
The Now Corp
ISIN: US67010T1034
Shares Out.:
305.402M1 Shares Float: 305.402M2
TV:
SA:
YF:
GF:
BA:
MS:
0.0001 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About The Now Corp.

The Now Corporation engages in development and commercialization of alternative energy technologies, such as wind power and the revitalization of abandoned oil wells. The company offers the exoPOWER windTURBINE System, a proprietary, patent-pending wind turbine technology designed to enhance wind power generation efficiency. The company was founded in 1993 and is headquartered in Portland, Oregon.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
9M%
United Therapeutics Corp.
UTHR
$13.18B
2M%
Neurocrine Biosciences, Inc.
NBIX
$10.21B
1M%
Viatris Inc.
VTRS
$9.32B
1M%
Lantheus Holdings, Inc.
LNTH
$6.94B
948K%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Merck KGaA
MRK
$59.42B
52.43B EUR
8M%
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
7M%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
6M%
Haleon plc
HLN
$45.57B
34.34B GBP
6M%
Galderma Group AG
GALD
$23.06B
19.13B CHF
3M%